Live Breaking News & Updates on Kwality Pharmaceuticals Limited
Stay updated with breaking news from Kwality pharmaceuticals limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kwality Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 696.5 million. ....
Kwality Pharmaceuticals Limited has successfully completed the EU GMP Inspection for its Cephalosporin and Oncology manufacturing unit II at Himachal Pradesh. ....
Activist Yogita Bhayana moves HC over Remdesivir supply ANI 06 May 2021, 21:55 GMT+10 New Delhi [India], May 6 (ANI): Social Activist Yogita Bhayana moved the Delhi High Court seeking direction to Kwality Pharmaceuticals Limited to supply the available units of the Remdesivir and further directed it to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi. Issue a Writ of Mandamus or any other appropriate Writ, Order or Direction thereby directing the Respondents-UOI to direct respondent number four (Kwality Pharmaceuticals Limited) to supply the available units of the Remdesivir and further direct to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi, said the petition filed through advocates Shrish Kumar and Pramod Kumar. ....
Representative image ANI | Updated: May 06, 2021 16:36 IST New Delhi [India], May 6 (ANI): Social Activist Yogita Bhayana moved the Delhi High Court seeking direction to Kwality Pharmaceuticals Limited to supply the available units of the Remdesivir and further directed it to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi. Issue a Writ of Mandamus or any other appropriate Writ, Order or Direction thereby directing the Respondents-UOI to direct respondent number four (Kwality Pharmaceuticals Limited) to supply the available units of the Remdesivir and further direct to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi, said the petition filed through advocates Shrish Kumar and Pramod Kumar. ....